Search - tctmd.com

Displaying 101 - 120 of 598

Sort: Relevancy | Date

News Conference News EACTS 2024

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Yael L. Maxwell

October 21, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Todd Neale

September 26, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

Yael L. Maxwell

August 14, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Podcast TCTMD Talking Points

Four-Year Results: The EVOLUT Low Risk Trial

June 12, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

Presentation NY Valves 2024

SAVR Transaxillary Approach: Pushing the Boundaries

Presenter: Joerg Kempfert

June 07, 2024

Presentation NY Valves 2024

Transaxillary Non-Robotic SAVR – Yet Another Option

Presenter: Joerg Kempfert

June 06, 2024

Presentation NY Valves 2024

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Advertisement

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

MACE in CV Trials: Has the Outcome Outlived Its Role?

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

TCTMD’s Top 10 Most Popular Stories for August 2024

What’s Going to Be Hot at ESC 2024

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

National Data Point to Soaring TAVI Rates in Patients Under 65

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Four-Year Results: The EVOLUT Low Risk Trial

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

SAVR Transaxillary Approach: Pushing the Boundaries

Transaxillary Non-Robotic SAVR – Yet Another Option

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

SAVR After TAVR: A Dangerous Epidemic?

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content